Will 2017 Be a Make or Break Year for FibroGen?
FibroGen could be a very important stock in its sector in 2017, with its data from multiple studies coming out early in the year.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 181
7 Key FDA Decisions and Catalysts Expected in January and February
24/7 Wall St. has collected several catalysts for biotech and pharmaceutical companies that are coming up in the first two months of 2017.
EndoLogix Recovers Slightly After Resuming Shipments
Endologix shares dropped sharply on news of a temporary hold on the shipments of its abdominal aortic aneurysms products, but now that the company is resuming shipments, the stock has recovered somewhat.
Cempra Shares Get Halved After Receipt of CRL From the FDA
Shares of Cempra were halved on Thursday after the company received a Complete Response Letter from the U.S. Food and Drug Administration (FDA).
Galena Rises on FDA Approval
Galena Biopharma, Inc. (NASDAQ: GALE) saw its shares jump on Wednesday after a key U.S. Food and Drug Administration (FDA) approval. The company announced that it has confirmed the regulatory pathway to advance GALE-401…
Short Interest Rises in Major Pharma
The December 15 short interest data have been compared with the previous figures, and short interest increased in most of these selected pharmaceutical stocks.
Biotech Short Interest Sinks
The December 15 short interest data have been compared with the previous report, and short interest was down in most of the selected biotech stocks.
10 US Cities With the Shortest Life Expectancies
The cities where life expectancies are the shortest tend to report lower household incomes and more unhealthy behaviors than cities with longer life expectancies.
Teva Agrees to Pay Over $500 Million for FCPA Violations
The SEC has announced that Teva Pharmaceutical Industries has agreed to pay over $519 million to settle charges that it violated the Foreign Corrupt Practices Act by paying bribes to foreign government officials.
Endo International Is America’s Least Successful Company of 2016
Drugmakers' stocks can get clobbered by regulatory investigations. That's what happened to this year's least successful company: Endo International, which has seen its share price fall by more than 73%.
10 US Cities With the Longest Life Expectancies
These 10 cities had the longest life expectancies in the entire United States. They tend to have certain characteristics common.
Amphastar Slides After Receiving CRL From the FDA
Shares of Amphastar Pharmaceuticals fell on Tuesday after the company announced that a subsidiary had received a Complete Response Letter from the FDA.
Endologix Sinks on Temporary Shipping Hold
Although the week between Christmas and New Year’s is not a heavily traded one, one company is making a case for it with a double-digit move on Tuesday.
Seattle Genetics Shares Hammered on Clinical Holds
Seattle Genetics shares were down double-digits after the company announced that the FDA has placed holds on several early-stage clinical trials of its leukemia drug candidate.
Visterra Gears Up for IPO
Visterra has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).